Beshar Luke M
- SEC CIK
- 0001192128
No open-market purchases or sales filed in the past year.
Current role at each company
- TARA Protara Therapeutics, Inc.Directoras of Jun 16, 2026
- OMGA Omega Therapeutics, Inc.Directoras of Jun 9, 2023
- Trillium Therapeutics Inc.Directoras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Beshar Luke M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TARA Protara Therapeutics, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2022 (view filing) | Jun 30 | 5 days | Beshar Luke MDirector | PPurchase | +10.0K | $3.10 | +$31.0K | +5.3%198.0K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Beshar Luke MDirector | PPurchase | +10.0K | $4.25 | +$42.5K | +5.6%188.0K after | |
| Mar 14, 2022 (view filing) | Mar 10 | 4 days | Beshar Luke MDirector | PPurchase | +10.0K | $4.46 | +$44.6K | +6.0%178.0K after |